Dr. Kenneth Ho-Ming Yu, MD, MS

  • New York, NY
  • Medical oncologist
NPI1073554440PAC ID7517996051
Medicare services, 2024
786
Medicare patients, 2024
167
Part D claims, 2024
1,002
Publications
94
Clinical trials
7
Practice address
1275 York Avenue, New York, NY 10065
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Memorial Sloan Kettering Cancer Center

Hospital · New York, New York

See all 7 affiliations

Find Dr. Yu's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Kenneth Ho-Ming Yu is a medical oncologist in New York, New York

Dr. Yu practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Yu's NPI, 1073554440, was assigned on June 9, 2006. Dr. Yu graduated from The Johns Hopkins University School of Medicine in 1999. Dr. Yu's New York license number on file is 257085.

NPI and contact details
Medicare PAC ID
7517996051
NPI enumeration date
June 9, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
53
Medical school graduation
1999

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Kenneth Ho-Ming Yu practices at Memorial Sloan Kettering Cancer Center in New York, New York

Dr. Yu's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Source: Dmand AI Affiliation Data

Dr. Kenneth Ho-Ming Yu is affiliated with 4 sites of care and 3 medical groups

Dr. Yu's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Yu to 3 more group practices and clinics and 2 medical groups, each named with a free account.

See all 7 affiliations for Dr. Yu

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Kenneth Ho-Ming Yu's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yu practices, 4 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Memorial Sloan Kettering Cancer CenterAvailable with a free account
+3 more sites and 2 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Yu practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Memorial Sloan Kettering Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Kenneth Ho-Ming Yu is one of 458 medical oncologists in New York

Medical oncology is Dr. Yu's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Yu is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Yu's licenses on file in 3 states: New York, New Jersey and Pennsylvania.

Specialties and state licenses

  • Medical oncology, New YorkPrimaryLicense 257085 · 2010 to 2025 · taxonomy 207RX0202X
  • New Jersey license2019 to 2027
  • Internal medicine, PennsylvaniaLicense MD419942 · 2000 to 2010 · taxonomy 207R00000X

Medical oncologists near Dr. Yu

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Kenneth Ho-Ming Yu billed Medicare for 786 services in 2024

CMS data shows 786 Medicare services from Dr. Yu across 4 procedure codes in 2024, for 167 Medicare patients. Medicare paid $73,868 for them.

Medicare services, 2024786
Medicare patients167
Paid by Medicare$73,868
Procedure codes4

Dr. Yu's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 7722024: 7862%

Where Dr. Yu's Medicare services took place, 2024

  • In an office69488%
  • In a facility9212%

Dr. Yu compared with the New York median for medical oncologists, 2024

  • Dr. Yu
  • New York median
Medicare services
786vs 3402.3 times
Medicare patients
167vs 11249% above
Part D claims
748vs 1305.8 times

Medians across 421 medical oncologists in New York with Dmand AI profiles that report each measure.

Dr. Yu's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Yu

Need commercial claims for Dr. Yu?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Yu and other medical oncologists in New York.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Kenneth Ho-Ming Yu treated 167 Medicare patients in 2024, average age 75

CMS counts 167 Medicare patients who saw Dr. Yu in 2024. The largest group is 65 to 74, with 75 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yu's median patient age at 74, with 52% women.

Medicare patients, 2024167
Average age75
Average risk score2.85
Also on Medicaid22%

Dr. Yu's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Yu's Medicare patients by sex, 2024

  • Women7847%
  • Men8953%

Chronic conditions among Dr. Yu's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis51%
  4. Diabetes45%
  5. Ischemic heart disease44%
  6. Anxiety37%
  7. Cancer37%
  8. Mood disorders29%

Share of Medicare patients with each condition. A patient can have several.

Dr. Yu's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 74

Patient panel by sex, all payers

  • Women52%
  • Men48%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Kenneth Ho-Ming Yu wrote 1,002 Medicare Part D claims in 2024

In 2024, Dr. Yu wrote 1,002 Medicare Part D claims for 125 patients. 72% of them were for generic drugs. CMS names the drug for 748 of them, across 26 drugs with 11 or more claims each, at $495,118 in total drug cost. In 2023, CMS named 540 claims across 21 drugs.

Part D claims, 20241,002
Drugs named by CMS26
Total drug cost$495,118
Part D patients125

Dr. Yu's Part D claims by kind of drug, 2024

  • Generic724 claims72%
  • Brand-name and other278 claims28%

Dr. Yu's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Yu's Part D claims, 2024

  • Opioids12%118 of 1,002 claims
  • Antibiotics3%32 of 1,002 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 5402024: 74839%

Drugs named by CMS: 26 in 2024, 21 in 2023.

See all prescribing by Dr. Yu

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Kenneth Ho-Ming Yu scored 80 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Yu for performance year 2024, reported as part of a group. Dr. Yu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yu as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Yu's MIPS scores, performance year 2024

  • 80of 100Final score
  • 70.5of 100Quality
  • 40of 100Improvement Activities
  • 69of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Yu by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Kenneth Ho-Ming Yu has 94 publications on record

Dmand AI links 94 papers to Dr. Yu, published from 2011 to 2025. 2018 was the busiest year, with 12. The most frequent topics are Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal and Adenocarcinoma. Dr. Yu has published most often in Cancer. Dr. Yu's most frequent co-authors are David P. Kelsen, MD, Eileen M. O'Reilly, MD and Anna M. Varghese, MD.

Papers94
Years published2011 to 2025

Dr. Yu's papers by year, 2016 to 2025

Topics Dr. Yu writes about most

  • Pancreatic Neoplasms
  • Carcinoma, Pancreatic Ductal
  • Adenocarcinoma
  • Antineoplastic Combined Chemotherapy Protocols
  • Germ-Line Mutation
  • Deoxycytidine
  • Gemcitabine
  • Antineoplastic Agents

Dr. Yu's most frequent co-authors

Recent publications by Dr. Yu

See all 94 publications and co-authors

See who Dr. Yu researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Yu works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Kenneth Ho-Ming Yu has worked on 7 clinical trials

Dmand AI links Dr. Yu to 7 clinical trials. 5 are still active or recruiting. Conditions studied include Pancreatic Neoplasms, Pancreatic Diseases and Carcinoma, Adenoid Cystic. Memorial Sloan Kettering Cancer Center sponsors the most, 5.

Clinical trials with Dr. Yu by phase

  1. 1Phase 1: 1 trial
  2. 1Phase 1/2: 1 trial
  3. NonePhase 2: no trials
  4. NonePhase 3: no trials
  5. NonePhase 4: no trials

Conditions in Dr. Yu's trials

  • Pancreatic Neoplasms
  • Pancreatic Diseases
  • Carcinoma, Adenoid Cystic
  • Pancreatic Cyst
  • Thromboembolism

Investigators on the most trials with Dr. Yu

Recent clinical trials with Dr. Yu

See all 7 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Kenneth Ho-Ming Yu received $86,317 in industry payments from 2016 to 2025

CMS Open Payments shows 113 general payments to Dr. Yu from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 76% of the total. Ipsen Biopharmaceuticals, Inc paid the most, $46,320.

General payments to Dr. Yu by program year, 2016 to 2025

General payments to Dr. Yu by kind, 2016 to 2025

$86.3Kin total
  • Consulting fees$65,98476%
  • Travel and lodging$13,90816%
  • Food and beverage$3,4094%
  • Speaker and faculty fees$2,9003%
  • Education$1170%

Companies that paid Dr. Yu the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Yu

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Kenneth Ho-Ming Yu graduated from The Johns Hopkins University School of Medicine

Dr. Yu graduated from The Johns Hopkins University School of Medicine in 1999.

  1. Medical schoolThe Johns Hopkins University School of Medicine
  2. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Kenneth Ho-Ming Yu accepts plans from 13 insurance carriers

Dr. Yu is in network with 13 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.

  • Aetna
  • Excellus BlueCross BlueShield
  • Blue Cross Blue Shield of Michigan
  • United Healthcare
  • Blue Cross Blue Shield of Massachusetts
  • HCSC
  • MVP Health Care
  • Regence Health Plans
  • +5 more carriersWith a free account

Plan types Dr. Yu accepts, by number of carriers

  1. Medicare8
  2. PPO8
  3. POS5
  4. EPO4
  5. HMO4
  6. Medicaid1

Source: Dmand AI Insurance Network Data

Sources for Dr. Kenneth Ho-Ming Yu's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Kenneth Ho-Ming Yu

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Kenneth Ho-Ming Yu's NPI number?

Dr. Kenneth Ho-Ming Yu's NPI number is 1073554440. It was assigned on June 9, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Kenneth Ho-Ming Yu?

Dr. Kenneth Ho-Ming Yu is a medical oncologist in New York, New York. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Kenneth Ho-Ming Yu practice?

Dr. Yu practices at 1275 York Avenue, New York, NY 10065. Dr. Yu's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Yu to 3 group practices and clinics and 2 medical groups.

What is Dr. Kenneth Ho-Ming Yu's medical license number?

Dr. Yu's New York license number on file is 257085, one of the licenses on file in 3 states.

Which states has Dr. Kenneth Ho-Ming Yu been licensed in?

Dmand AI has state licenses on file for Dr. Yu in New York (2010 to 2025), New Jersey (2019 to 2027) and Pennsylvania (2000 to 2010).

Which hospitals is Dr. Kenneth Ho-Ming Yu affiliated with?

Dr. Yu practices at Memorial Sloan Kettering Cancer Center in New York, New York.

What medical group is Dr. Kenneth Ho-Ming Yu part of?

Dr. Yu is linked to Memorial Sloan Kettering Cancer Center. Dmand AI links Dr. Yu to 2 more medical groups.

Does Dr. Kenneth Ho-Ming Yu accept Medicare?

Yes. CMS data shows Dr. Yu billed Medicare for 786 services in 2024, and Dr. Yu accepts Medicare assignment.

Does Dr. Kenneth Ho-Ming Yu offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Yu as offering telehealth services.

What is Dr. Kenneth Ho-Ming Yu's MIPS score?

Dr. Yu's MIPS final score for performance year 2024 is 80 out of 100, reported as part of a group.

Show 10 more questionsShow fewer questions

How many Medicare patients does Dr. Kenneth Ho-Ming Yu see?

CMS counts 167 Medicare patients who saw Dr. Yu in 2024, with an average age of 75.

Is Dr. Kenneth Ho-Ming Yu board certified?

Yes. Dr. Yu is board certified in medical oncology by the American Board of Internal Medicine.

What services does Dr. Kenneth Ho-Ming Yu bill to Medicare?

In 2024, Dr. Yu's most billed Medicare services were office visit, established patient (99214), hospital inpatient care (99233) and office visit, new patient (99205).

Where did Dr. Kenneth Ho-Ming Yu go to medical school?

Dr. Yu graduated from The Johns Hopkins University School of Medicine in 1999.

What drugs does Dr. Kenneth Ho-Ming Yu prescribe most?

In 2024 Medicare Part D data, Dr. Yu's most prescribed drugs by claims were Pantoprazole Sodium, Zenpep and Creon.

Has Dr. Kenneth Ho-Ming Yu received payments from drug or device companies?

CMS Open Payments shows $86,317 in general payments to Dr. Yu from 13 companies from 2016 to 2025. The largest total came from Ipsen Biopharmaceuticals, Inc.

How long has Dr. Kenneth Ho-Ming Yu been practicing?

Dr. Yu graduated from medical school in 1999, 27 years ago.

Does Dr. Kenneth Ho-Ming Yu do research?

Dmand AI links 94 publications to Dr. Yu, published from 2011 to 2025. Dr. Yu has worked on 7 clinical trials.

Who does Dr. Kenneth Ho-Ming Yu publish with?

Dr. Yu's most frequent co-authors are David P. Kelsen, MD (27 shared papers), Eileen M. O'Reilly, MD (27 shared papers) and Anna M. Varghese, MD (24 shared papers).

What insurance does Dr. Kenneth Ho-Ming Yu accept?

Dr. Yu is in network with 13 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.

Selling to medical oncology practices?

See medical oncologists in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)